Delta-Fly Pharma Completes Third Unsecured Bond Issue for EVO Fund

TOKYO, Jul 23 (Pulse News Wire) – Delta-fly Pharma,inc. (4598.T) confirmed the completion of the total issuance amount of July 22, 2026 for its third unsecured bond issue to EVO FUND.

The bonds, totaling ¥29 billion, were fully paid up on July 23, 2026. Key details of the bonds include: - Total amount: ¥29 billion - Individual bond amount: ¥1 - Payment date: July 23, 2026 - Redemption date: August 10, 2028 - Interest rate: 0.0% per annum - Issue price: Par value ¥1 for ¥100 - Redemption price: Par value ¥1 for ¥100 Redemption methods include full repayment at maturity, with optional early redemption clauses available under certain conditions.

For instance, upon five business days' notice, the company can redeem outstanding bonds at par value ¥1 for ¥100. Additionally, bondholders can request early redemption under specific circumstances outlined in the agreement.

For more detailed information, refer to the July 22 press release titled “Third Party Allocation for the 12th Subscription Warrant (Exercise Price Adjustment Clause) and Third Unsecured Bond (Private Placement) Issuance and Subscription Warrant Repurchase Agreement.”.